New Balance Women's Fresh Foam X Evoz V3 Running Shoe

Analyzed on

552Total Reviews

Road Running

n/a

Company Review Grade:

New Balance

9,882 Total Products

New Balance Women's Fresh Foam X Evoz V3 Running Shoe

Analyzed on

Sold by New Balance

A

Fakespot review grade

A

This analysis is outdated. Please reanalyze.

Ask Fakespot Chat questions about this productAlpha

Initializing Fakespot Chat

System error,

Loading suggested questions

Suggested Questions

No suggested questions were found

Please note: The content is generated by an AI language model based on reviews. We are constantly improving the accuracy, however, its outputs may contain errors or offensive content from certain reviews. Please report any errors or offensive content to us. Also, please note that we will not collect your questions unless you click the thumbs up/down button to provide feedback. The answers displayed will be stored by us so if another Fakespotter asks a similar question we can provide them an answer faster. Your feedback will only help us make Fakespot Chat better! By using Fakespot Chat, you agree to Fakespot's terms of use and privacy notice.

Pros & Cons

Update Pros and Cons

The AI used to provide these results are constantly improving. These results might change.

pros

See Details

pros

Features with many positive mentions

See Details

Comfortable Design

Customers rave about the comfortable design of these New Balance Women's Fresh Foam X Evoz V3 Running Shoes. They are praised for their comfortability during workouts, gym sessions, and daily wear. The shoes are also noted to be stylish with various color options available.

Supportive Sole

Customers with various foot conditions, including plantar fasciitis, fibromyalgia, and orthotics, have reported that the New Balance Women's Fresh Foam X Evoz V3 Running Shoe provides excellent support and comfort for their feet. The shoe's forgiving sole has helped alleviate pain and discomfort for many users, making it a popular choice among those who need extra cushioning and support. Some customers have also noted the shoe's lightweight design and versatility, allowing them to use it for various activities such as running, weight lifting, and cardio machines

Wide Toe Box

Customers generally praise the wide toe box of the New Balance Women's Fresh Foam X Evoz V3 Running Shoe for providing a comfortable and stable fit, especially for those with wider feet or medical conditions like posterior tibial tendonitis. However, some customers have noted that the shoe runs slightly narrower than expected, which may not be ideal for those who typically require a wide size in this brand.

Was this feature helpful?

Highlights

The AI used to provide these results are constantly improving. These results might change.

Quality

New balance quality has always been great, in my opinion.

These are a little stiffer than my other fresh foam but they turned out to be perfect for cycling with flat pedals.

I have very wide feet and my feet hurt at the end of the day most days.

The support is good as well and they are durable so far.

Price

Very good to run in and super affordable!

I decided to try out this shoe because of the cheaper price point.

I am a big fan of fresh foam 1080 but that is an expensive shoe to use for walking.

Packaging/appearance

Size and product received was in excellent condition.

Competitiveness

5 wide, which is a full size up and wider than i normally would order in this brand, and the fit is almost perfect when wearing... Read More

I bought two different new balance sneakers and the other pair (new balance women's 608 v5 cross trainer) does not compare to this one.

I’ve tried alot of shoes- dansco, sketchers, hoka, crocs, sloggers, nike, just to name a few.

Overview

How are reviewers describing this item?
comfortable, wide, new, great and fit.

Our engine has profiled the reviewer patterns and has determined that there is minimal deception involved.

Our engine has discovered that over 90% high quality reviews are present.

This product had a total of 552 reviews as of our last analysis date on Oct 24 2024.